A bioactive designer cytokine for human hematopoietic progenitor cell expansion

[1]  S. Rose-John,et al.  The family of the IL‐6‐Type cytokines: Specificity and promiscuity of the receptor complexes , 1997, Proteins.

[2]  K. Yasukawa,et al.  Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells , 1996, The Journal of experimental medicine.

[3]  S. Rose-John,et al.  Alternative assay procedures for cytokines and soluble receptors of the IL-6 family. , 1996, Journal of immunological methods.

[4]  A. Buj-Bello,et al.  Characterization of a multicomponent receptor for GDNF , 1996, Nature.

[5]  R. Cortese,et al.  Engineering human interleukin‐6 to obtain variants with strongly enhanced bioactivity. , 1996, The EMBO journal.

[6]  H. Kiyama,et al.  Accelerated Nerve Regeneration in Mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma , 1996, The Journal of experimental medicine.

[7]  J A Wells,et al.  Binding in the growth hormone receptor complex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. Sehgal,et al.  Interleukin‐6‐Type Cytokines a , 1995, Annals of the New York Academy of Sciences.

[9]  K. Yasukawa,et al.  gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[10]  C. Peschel,et al.  Human interleukin-4 enhances stromal cell-dependent hematopoiesis: costimulation with stem cell factor. , 1994, Blood.

[11]  C. Begley,et al.  Cloning of a murine IL‐11 receptor alpha‐chain; requirement for gp130 for high affinity binding and signal transduction. , 1994, The EMBO journal.

[12]  S. Rose-John,et al.  Identification of two novel regions of human IL-6 responsible for receptor binding and signal transduction. , 1994, Journal of immunology.

[13]  P. Heinrich,et al.  Soluble receptors for cytokines and growth factors: generation and biological function. , 1994, The Biochemical journal.

[14]  S. Ziegler,et al.  Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Akira,et al.  Cytokine signal transduction , 1994, Cell.

[16]  P. Heinrich,et al.  Structure-function analysis of interleukin-6 utilizing human/murine chimeric molecules. Involvement of two separate domains in receptor binding. , 1993, The Journal of biological chemistry.

[17]  K. Yasukawa,et al.  Structure‐function analysis of human IL‐6 receptor: dissociation of amino acid residues required for IL‐6‐binding and for IL‐6 signal transduction through gp130. , 1993, The EMBO journal.

[18]  A. Porgador,et al.  Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. , 1992, Cancer research.

[19]  M. Ultsch,et al.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.

[20]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[21]  M. Carson.  RIBBONS 2.0 , 1991 .

[22]  G. Yancopoulos,et al.  The receptor for ciliary neurotrophic factor. , 1991, Science.

[23]  T. Saito,et al.  Purification and characterization of soluble human IL-6 receptor expressed in CHO cells. , 1990, Journal of biochemistry.

[24]  F. D. Di Padova,et al.  Structure-function analysis of human IL-6. Epitope mapping of neutralizing monoclonal antibodies with amino- and carboxyl-terminal deletion mutants. , 1990, Journal of immunology.

[25]  T. Hirano,et al.  Studies on the structure and regulation of the human hepatic interleukin-6 receptor. , 1990, European journal of biochemistry.

[26]  T. Hirano,et al.  Structure‐function analysis of human interleukin‐6 , 1990, FEBS letters.

[27]  T. Hirano,et al.  Interleukin-6 is a potent thrombopoietic factor in vivo in mice. , 1989, Blood.

[28]  K. D. Hardman,et al.  Single-chain antigen-binding proteins. , 1988, Science.

[29]  T. Taniguchi,et al.  Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. , 1988, Science.

[30]  R. Bruccoleri,et al.  Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[31]  T. Taniguchi,et al.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin , 1986, Nature.

[32]  S. Rose-John,et al.  Yeast expression of the cytokine receptor domain of the soluble interleukin-6 receptor. , 1996, Journal of immunological methods.